Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Investment Opportunities & Stratgies for the $16.5 Billion Blood Glucose Test Strips Market, 2026-2034 | Diabetes Prevalence and Home Monitoring Demand Driving Industry Growth

globenewswire.com
ABT Abbott is mentioned as a prominent medical technology company in the blood glucose test strips market, indicating its participation and potential influence in this growing sector. MDT Medtronic is listed as a prominent medical technology company within the blood glucose test strips market, suggesting its involvement and potential role in the industry's growth. JNJ Johnson & Johnson MedTech is identified as a key player in the blood glucose test strips market, implying its presence and potential contributions to the sector's expansion. BDX Becton Dickinson is named as a prominent medical technology company in the blood glucose test strips market, indicating its involvement and potential to benefit from market growth. BSX Boston Scientific is mentioned as a prominent medical technology company in the blood glucose test strips market, suggesting its participation and potential role in the industry's growth. CTAS ConvaTec is listed as a prominent company within the blood glucose test strips market, indicating its involvement and potential to capitalize on the sector's expansion. TLF Teleflex is mentioned as a prominent company in the blood glucose test strips market, suggesting its participation and potential to benefit from the industry's growth.

Investment Opportunities & Stratgies for the $16.5 Billion Blood Glucose Test Strips Market, 2026-2034 | Diabetes Prevalence and Home Monitoring Demand Driving Industry Growth Dublin, Aug. 31, 2026 (GLOBE NEWSWIRE) -- The "Blood Glucose Test Strips Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type, Diabetes Type, End User, Distribution Channel" has been added to ResearchAndMarkets.com's offering.

The global blood glucose test strips market is valued at US$16.5 billion in 2026 and is projected to reach US$23.6 billion by 2034, expanding at a compound annual growth rate of 6.9%. Market growth is supported by the rising prevalence of diabetes, aging populations, broader access to screening, increased adoption of home-based glucose monitoring, and continued demand for reliable point-of-care testing.

Blood Glucose Test Strips Market Overview

Blood glucose test strips remain essential consumables across hospitals, clinics, diagnostic laboratories, physician offices, pharmacies, and home-care settings. Purchasing decisions increasingly reflect measurement accuracy, meter compatibility, regulatory compliance, supply continuity, ease of use, data connectivity, and total operating value. Healthcare providers and consumers also place greater emphasis on trusted brands, validated quality, dependable replenishment, and post-sale support.

The blood glucose test strips value chain includes biomaterials, enzymes and reagents, precision manufacturing, quality assurance, regulatory clearance, distribution, clinical training, retail fulfillment, and post-market surveillance. Manufacturers are strengthening supplier networks, localizing selected production activities, improving inventory planning, and securing critical inputs to reduce lead times and protect product availability.

Technology development is focused on improved strip accuracy, lower sample-volume requirements, faster results, enhanced traceability, connected glucose meters, digital recordkeeping, and integration with diabetes management platforms. Suppliers that combine high-quality test strips with compatible hardware, analytics, mobile applications, and workflow support are better positioned to strengthen customer retention and defend pricing.

Key Market Growth Drivers and Challenges

Despite the positive outlook, the market faces reimbursement pressure, pricing competition, hospital budget constraints, raw material volatility, regulatory approval requirements, and the need for consistent performance across diverse operating conditions. Margin protection will depend on product differentiation, manufacturing efficiency, supplier diversification, portfolio optimization, and reliable regional distribution.

Market Segmentation

By Product Type

By End User

By Diabetes Type

By Distribution Channel

Regional Blood Glucose Test Strips Market Outlook

North America remains a major market due to established diabetes care infrastructure, widespread home monitoring, advanced digital health adoption, and reimbursement-supported healthcare services. Europe continues to emphasize product quality, clinical evidence, regulatory compliance, and standardized diabetes management. Asia-Pacific is expected to generate significant growth as diabetes prevalence rises, healthcare access expands, manufacturing capacity increases, and hospital and pharmacy networks develop.

Markets across the Middle East, Africa, South America, and Central America are benefiting from public health investment, private-sector expansion, improving diagnostic access, and greater awareness of diabetes management. Commercial performance across these regions will depend on affordability, local partnerships, distribution reach, regulatory execution, and continuity of supply.

The report provides market data and forecasts for 30 countries across North America, Europe, Asia-Pacific, the Middle East and Africa, and South and Central America. Covered markets include the United States, Canada, Mexico, Germany, the United Kingdom, France, Italy, Spain, China, Japan, India, South Korea, Australia, Saudi Arabia, South Africa, the UAE, Brazil, Argentina, Chile, and other strategically important economies.

Competitive Intelligence and Company Analysis

Competition in the blood glucose test strips market is shaped by product accuracy, regulatory expertise, manufacturing scale, brand recognition, meter compatibility, distribution strength, digital integration, and customer service. Leading suppliers are moving beyond individual product sales toward broader diabetes management ecosystems that combine consumables, monitoring devices, software, analytics, training, and replenishment services.

The competitive assessment reviews prominent medical technology and healthcare companies, including Abbott, Medtronic, Johnson & Johnson MedTech, Becton Dickinson, Terumo, Fresenius Kabi, Baxter, Boston Scientific, Mindray, Nihon Kohden, ConvaTec, Teleflex, and other industry participants. It examines company strategies, product portfolios, operational footprints, financial indicators, partnerships, acquisitions, technology collaborations, investments, and regional expansion initiatives.

Report Scope and Strategic Value

The report combines primary interviews with industry experts and secondary research from government publications, trade databases, industry associations, regulatory sources, and verified company disclosures. The methodology incorporates data triangulation, statistical analysis, value chain mapping, supply-demand assessment, Porter's Five Forces analysis, and scenario-based forecasting.

The study supports decisions related to market entry, capacity planning, sourcing, pricing, product development, competitive positioning, partnerships, and investment prioritization. It identifies high-growth product categories, end-user segments, distribution channels, regional opportunities, supply chain risks, pricing trends, trade flows, regulatory developments, and emerging technology priorities.

Scenario analysis evaluates the potential effects of macroeconomic volatility, geopolitical disruption, sanctions, trade policy changes, supply interruptions, and evolving healthcare regulations. The report also assesses recent partnerships, investments, acquisitions, product developments, and regional expansions influencing the competitive environment.

Additional Report Support

The report gives healthcare companies, manufacturers, distributors, investors, and strategy teams a decision-ready view of the blood glucose test strips market. Its findings help stakeholders identify growth opportunities, anticipate competitive moves, strengthen supply resilience, refine go-to-market strategies, and prioritize investments through 2034.

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/puiv9b

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.